ClinicalTrials.Veeva

Menu

Minimally Invasive Surgery (MIS) for Spine Metastases

Mount Sinai Health System logo

Mount Sinai Health System

Status

Completed

Conditions

Spine Metastases

Study type

Observational

Funder types

Other

Identifiers

NCT02367378
GCO 12-0161

Details and patient eligibility

About

The purpose of this study is to collect information on the effect of minimally invasive spine tumor decompression on treated patients. This treatment option is less invasive that the standard surgical decompression and is expected to result in better wound healing, decreased tissue trauma, and decreased pain after surgery.

Full description

This is a prospective study designed to analyze the impact that minimally invasive spine tumor decompression has upon quality of life, neurological morbidity, pain, and mortality. Prospective findings will be compared with historical controls to determine whether the minimally invasive approach offers better outcomes than traditional treatment methods.

Enrollment

14 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • undergone minimally invasive surgery
  • over 18 years of age

Exclusion criteria

  • unable to give consent

Trial design

14 participants in 2 patient groups

MIS
Description:
Those who received minimally invasive surgical procedures
Control
Description:
Those who received treatments which include surgical resection, chemotherapy, and radiotherapy.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems